AngioDynamics, Inc.
ANGO · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $292,498 | $303,914 | $338,752 | $316,219 |
| % Growth | -3.8% | -10.3% | 7.1% | – |
| Cost of Goods Sold | $134,793 | $149,216 | $164,506 | $150,487 |
| Gross Profit | $157,705 | $154,698 | $174,246 | $165,732 |
| % Margin | 53.9% | 50.9% | 51.4% | 52.4% |
| R&D Expenses | $26,222 | $31,512 | $29,883 | $30,739 |
| G&A Expenses | $42,092 | $41,164 | $40,003 | $38,451 |
| SG&A Expenses | $145,227 | $143,982 | $144,252 | $133,752 |
| Sales & Mktg Exp. | $103,135 | $102,818 | $104,249 | $95,301 |
| Other Operating Expenses | $26,210 | $171,639 | $51,292 | $29,712 |
| Operating Expenses | $197,659 | $347,133 | $225,427 | $194,203 |
| Operating Income | -$39,954 | -$192,435 | -$51,181 | -$28,471 |
| % Margin | -13.7% | -63.3% | -15.1% | -9% |
| Other Income/Exp. Net | $5,922 | $797 | -$3,256 | -$1,478 |
| Pre-Tax Income | -$34,032 | -$191,638 | -$54,437 | -$29,949 |
| Tax Expense | -$39 | -$7,289 | -$1,995 | -$3,402 |
| Net Income | -$33,993 | -$184,349 | -$52,442 | -$26,547 |
| % Margin | -11.6% | -60.7% | -15.5% | -8.4% |
| EPS | -0.83 | -4.59 | -1.33 | -0.68 |
| % Growth | 81.9% | -245.1% | -95.6% | – |
| EPS Diluted | -0.83 | -4.59 | -1.33 | -0.68 |
| Weighted Avg Shares Out | 40,984 | 40,181 | 39,480 | 39,009 |
| Weighted Avg Shares Out Dil | 40,984 | 40,181 | 39,480 | 39,009 |
| Supplemental Information | – | – | – | – |
| Interest Income | $978 | $1,614 | $0 | $0 |
| Interest Expense | $0 | $0 | $2,702 | $688 |
| Depreciation & Amortization | $25,800 | $27,712 | $30,873 | $29,349 |
| EBITDA | $1,738 | -$6,132 | $12,194 | $11,132 |
| % Margin | 0.6% | -2% | 3.6% | 3.5% |